International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 498-502 doi: 10.5281/zenodo.16789986
Original Article
Cervical Cytological Abnormalities Among Pregnant Women: A Hospital Based Study
 ,
 ,
 ,
Published
Aug. 10, 2025
Abstract

Background: Cervical cancer remains a leading cause of cancer-related deaths among women, particularly in developing countries like India and pregnancy offers a crucial opportunity for screening, as women are more likely to access healthcare during this period.

Objective: To determine the prevalence of abnormal cervical cytology in pregnant women and identify associated risk factors.

Methods: A cross-sectional study was conducted among 200 pregnant women attending antenatal OPD at Gauhati Medical College and Hospital from December 2023 to November 2024. Cervical smears were analyzed using the Bethesda System. Statistical analysis was performed using SPSS v20, with significance set at p<0.05.

Results: Among the participants, 71.9% had NILM, 24.6% had bacterial vaginosis, and 3.5% had candidiasis. A significant association was found between early age at coitarche and abnormal PAP findings (p=0.029). No significant associations were found with age, parity, contraceptive use and symptoms.

Conclusion: Integrating PAP smear screening into routine antenatal care is both feasible and effective. Early screening aids in detecting infections and potential cervical pathology, supporting better maternal health outcomes and highlighting the need for widespread implementation in resource-limited settings.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
1041 Views
437 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved